In the past several years, Greater Boston has cemented itself as the global epicenter of life sciences research. According to JLL’s Life Sciences Outlook report, the region consistently ranks in the top tier of U.S. life sciences clusters, with only San Francisco as its main adversary.
In fact, Boston and San Francisco took more than half of all venture capital dollars in the life sciences industry during 2018.
